Stan Erickson - Electromed Independent Director
| ELMD Stock | USD 13.94 0.19 1.34% |
Director
Mr. Stan K. Erickson is an Independent Director of the Company. He has served on the Board since November 2014. He is currently President and Chief Executive Officer of Liberty Capital, Inc., a company he cofounded in September 2013 to provide capital and advisory services. In November 2012, he retired from a 32year career at ZieglerCat, Inc., one of the largest Caterpillar dealers in the U.S. where he most recently served as President and Chief Operating Officer. Mr. Erickson is a veteran of the United States Marine Corporationration, earned a business degree from the University of Minnesota, a CPA Certification and began his business career as an auditor and tax professional. Mr. Erickson serves on the board of directors of Titan Machinery, Inc. and several private company boards, advisory committees and associations. Among other attributes, skills, experiences and qualifications, our Board believes that Mr. Erickson will be an asset to the Board due to Mr. Ericksons extensive experience in finance and management. since 2014.
| Age | 66 |
| Tenure | 10 years |
| Address | 500 Sixth Avenue NW, New Prague, MN, United States, 56071 |
| Phone | 952 758 9299 |
| Web | https://smartvest.com |
Electromed Management Efficiency
The company has return on total asset (ROA) of 0.0721 % which means that it generated a profit of $0.0721 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.104 %, meaning that it created $0.104 on every $100 dollars invested by stockholders. Electromed's management efficiency ratios could be used to measure how well Electromed manages its routine affairs as well as how well it operates its assets and liabilities. As of April 19, 2024, Return On Tangible Assets is expected to decline to 0.04. In addition to that, Return On Capital Employed is expected to decline to 0.08. At present, Electromed's Other Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 45.6 M, whereas Non Current Assets Total are forecasted to decline to about 5.4 M.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Robert Herbold | Agilent Technologies | 74 | |
| Heidi Fields | Agilent Technologies | 60 | |
| WahHui Chu | Mettler Toledo International | 69 | |
| William Miller | Waters | 70 | |
| William Parrett | Thermo Fisher Scientific | 71 | |
| John Thompson | Illumina | 68 | |
| Nelson Chai | Thermo Fisher Scientific | 55 | |
| Thomas Salice | Mettler Toledo International | 61 | |
| Sue Rataj | Agilent Technologies | 63 | |
| Connie Harvey | Mettler Toledo International | 52 | |
| Gary Hendrickson | Waters | 64 | |
| Richard Reese | Charles River Laboratories | 75 | |
| Tyler Jacks | Thermo Fisher Scientific | 59 | |
| Daniel Bradbury | Illumina | 56 | |
| Joshua Bekenstein | Waters | 56 | |
| Thomas Salice | Waters | 61 | |
| Richard Wallman | Charles River Laboratories | 69 | |
| George Massaro | Charles River Laboratories | 73 | |
| Hans Maerki | Mettler Toledo International | 71 | |
| James Mullen | Thermo Fisher Scientific | 62 | |
| Rebecca Chambers | Illumina | N/A | |
Management Performance
| Return On Equity | 0.1 | ||||
| Return On Asset | 0.0721 |
Electromed Leadership Team
Elected by the shareholders, the Electromed's board of directors comprises two types of representatives: Electromed inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Electromed. The board's role is to monitor Electromed's management team and ensure that shareholders' interests are well served. Electromed's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Electromed's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Amy Yanta, Quality Affairs | ||
| Diane Kaufman, Vice Resources | ||
| Thomas Hagedorn, Independent Director | ||
| Stan Erickson, Independent Director | ||
| William Eckles, Independent Director | ||
| Jeremy Brock, CFO | ||
| James Cunniff, Director President | ||
| Kathleen Skarvan, CEO and President and Director | ||
| George Winn, Vice Chairman of the Board | ||
| Brad Nagel, Chief Officer | ||
| William George, Secretary | ||
| Stephen Craney, Independent Chairman of the Board | ||
| Christopher Holland, Chief Officer | ||
| Lee Jones, Director | ||
| Bradley Nagel, Chief Officer |
Electromed Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Electromed a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.1 | ||||
| Return On Asset | 0.0721 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | 0.17 % | ||||
| Current Valuation | 109.65 M | ||||
| Shares Outstanding | 8.61 M | ||||
| Shares Owned By Insiders | 26.69 % | ||||
| Shares Owned By Institutions | 32.78 % | ||||
| Number Of Shares Shorted | 42.93 K | ||||
| Price To Earning | 23.66 X |
Pair Trading with Electromed
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Electromed position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Electromed will appreciate offsetting losses from the drop in the long position's value.Moving together with Electromed Stock
| 0.89 | FEMY | Femasys Financial Report 9th of May 2024 | PairCorr |
Moving against Electromed Stock
| 0.88 | IVP | Inspire Veterinary | PairCorr |
| 0.77 | TFX | Teleflex Incorporated Financial Report 2nd of May 2024 | PairCorr |
| 0.74 | EMBC | Embecta Corp Financial Report 10th of May 2024 | PairCorr |
| 0.6 | DYNT | Dynatronics Financial Report 9th of May 2024 | PairCorr |
| 0.57 | AHG | Akso Health Group | PairCorr |
The ability to find closely correlated positions to Electromed could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Electromed when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Electromed - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Electromed to buy it.
The correlation of Electromed is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Electromed moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Electromed moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Electromed can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Electromed. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. For information on how to trade Electromed Stock refer to our How to Trade Electromed Stock guide.You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Complementary Tools for Electromed Stock analysis
When running Electromed's price analysis, check to measure Electromed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Electromed is operating at the current time. Most of Electromed's value examination focuses on studying past and present price action to predict the probability of Electromed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Electromed's price. Additionally, you may evaluate how the addition of Electromed to your portfolios can decrease your overall portfolio volatility.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
Is Electromed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Electromed. If investors know Electromed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Electromed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.727 | Earnings Share 0.45 | Revenue Per Share 6.072 | Quarterly Revenue Growth 0.167 | Return On Assets 0.0721 |
The market value of Electromed is measured differently than its book value, which is the value of Electromed that is recorded on the company's balance sheet. Investors also form their own opinion of Electromed's value that differs from its market value or its book value, called intrinsic value, which is Electromed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Electromed's market value can be influenced by many factors that don't directly affect Electromed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Electromed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Electromed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Electromed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.